Market Cap

Mayne Pharma Group Limited Market Capitalization:

A$390.0 Million

AUD as of July 1, 2024

US$259.8 Million

business Mayne Pharma Group Limited Company Profile

Mayne Pharma Group Limited Main Stock Listing

ASX: MYX

Market Capitalization History of Mayne Pharma Group Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Roche $260.54 B
Novartis $243.50 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Mayne Pharma Group Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$493.4 M -93.70%
Jan. 1, 2023 A$7.83 B 1700.00%
Jan. 1, 2022 A$435.0 M -9.09%
Jan. 31, 2021 A$478.5 M -12.70%
Jan. 1, 2021 A$548.0 M -3.08%
Jan. 31, 2020 A$565.4 M -28.57%
Jan. 1, 2020 A$791.6 M -35.00%
Jan. 31, 2019 A$1.22 B -11.39%
Jan. 1, 2019 A$1.37 B 8.22%
Jan. 31, 2018 A$1.27 B 9.77%
Jan. 1, 2018 A$1.16 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Mayne Pharma Group Limited Categories

Australia languages Healthcare languages Drug Manufacturers—General
Australia Healthcare Australia Drug Manufacturers—General

Stocks & Indices

Mayne Pharma Group Limited has the following listings and related stock indices.


Stock: ASX: MYX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.